RAC 4.56% $1.84 race oncology ltd

[INTERVIEW] Breaking Barriers in Cancer Treatment: Race Oncology Pioneers a New Era with Bisantrene, page-33

  1. 3,299 Posts.
    lightbulb Created with Sketch. 360
    Do you think this promotional interview will help to attract more shareholders?
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.